Skip to main content

Table 8 Lesion Characteristics and Procedural Data

From: Clinical results of bioresorbable drug-eluting scaffolds in short and long coronary artery lesions using the PSP technique

 

Without Event

With Event

P-values

Number of Lesions

394

30

 

Target vessel, N (%)

 

 LAD

178 (45.3)

22 (73.3)

0.009

 CX

84 (21.3)

6 (20.0)

 

 RCA

128 (32.5)

2 (6.7)

 

 CABG

4 (1.0)

0 (0.0)

 

AHA/ACC lesion type, N (%)

 

 A

21 (5.3)

0 (0.0)

0.06

 B1

50 (12.7)

3 (10.0)

 

 B2

185 (47.0)

10 (33.3)

 

 C

138 (35.0)

17 (56.7)

 

Bifurcation, N (%)

4 (1.1)

0 (0.0)

0.64

Lesion length, mm

17.8 ± 12.7

24.3 ± 16.6

0.01

Length of scaffolded segment, mm

30.9 ± 20.5

38.8 ± 25.1

0.05

High pressure post-dilation, N (%)

347 (88.1)

26 (86.7)

0.82

Maximal inflation pressure, atm

16.4 ± 3.0

16.5 ± 3.5

0.92

Reference diameter, mm (post)

2.97 ± 0.97

2.86 ± 0.35

0.53

Minimal lumen diameter, mm (post)

2.52 ± 0.45

2.38 ± 0.41

0.99

Diameter stenosis, % (post)

13.37 ± 8.09

16.75 ± 9.05

0.04

Acute gain

1.26 ± 2.69

1.31 ± 0.36

0.31

  1. LAD left anterior descending artery, CX circumflex artery, RCA right coronary artery, CABG coronary artery bypass graft, AHA American Heart Association, ACC American College of Cardiology